It just reversed split last November to around 2.5 million shares and pretty much ceased operations. Now with the bio-tech they have ramped up operations. Shares are already double. Please tell me how the bio-tech which most likely never gets to market and won't produce a dime of revenue for years gets funded? Bio-techs take huge amounts of cash for research and trials. Those like myself who owned IGSM prior to the reverse have seen this all before.
Market Data 
Markets 
AI
